Melvyn I Marquis
Examiner (ID: 16161)
Most Active Art Unit | 1501 |
Art Unit(s) | 1402, 1505, 1503, 1501, 1712, 2200, 1754, 1401 |
Total Applications | 2620 |
Issued Applications | 2300 |
Pending Applications | 26 |
Abandoned Applications | 294 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11331697
[patent_doc_number] => 09522933
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-20
[patent_title] => 'Diagnosis of hereditary spastic paraplegias (HSP) by identification of a mutation in the ZFYVE26 gene or protein'
[patent_app_type] => utility
[patent_app_number] => 13/664868
[patent_app_country] => US
[patent_app_date] => 2012-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 17
[patent_no_of_words] => 20078
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13664868
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/664868 | Diagnosis of hereditary spastic paraplegias (HSP) by identification of a mutation in the ZFYVE26 gene or protein | Oct 30, 2012 | Issued |
Array
(
[id] => 10430642
[patent_doc_number] => 20150315654
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2015-11-05
[patent_title] => 'Chondroitin Sulfate Sulfotransferases and Proteoglycans as Cancer Biomarkers: Use of Expression and Methalytion Status'
[patent_app_type] => utility
[patent_app_number] => 13/573653
[patent_app_country] => US
[patent_app_date] => 2012-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 21032
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13573653
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/573653 | Chondroitin Sulfate Sulfotransferases and Proteoglycans as Cancer Biomarkers: Use of Expression and Methalytion Status | Sep 30, 2012 | Abandoned |
Array
(
[id] => 10430642
[patent_doc_number] => 20150315654
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2015-11-05
[patent_title] => 'Chondroitin Sulfate Sulfotransferases and Proteoglycans as Cancer Biomarkers: Use of Expression and Methalytion Status'
[patent_app_type] => utility
[patent_app_number] => 13/573653
[patent_app_country] => US
[patent_app_date] => 2012-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 21032
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13573653
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/573653 | Chondroitin Sulfate Sulfotransferases and Proteoglycans as Cancer Biomarkers: Use of Expression and Methalytion Status | Sep 30, 2012 | Abandoned |
Array
(
[id] => 8767984
[patent_doc_number] => 20130096021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'RECURRENT GENE FUSIONS IN BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/629188
[patent_app_country] => US
[patent_app_date] => 2012-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 30580
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13629188
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/629188 | RECURRENT GENE FUSIONS IN BREAST CANCER | Sep 26, 2012 | Abandoned |
Array
(
[id] => 9720237
[patent_doc_number] => 20140255937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'MUTATIONAL ANALYSIS OF JAK2'
[patent_app_type] => utility
[patent_app_number] => 14/348508
[patent_app_country] => US
[patent_app_date] => 2012-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 5731
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14348508
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/348508 | Mutational analysis of JAK2 | Sep 24, 2012 | Issued |
Array
(
[id] => 8606529
[patent_doc_number] => 20130011841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'Genetic Association of Polymorphisms in Perilipin (PLIN) Gene With Resistance to Weight Loss'
[patent_app_type] => utility
[patent_app_number] => 13/615204
[patent_app_country] => US
[patent_app_date] => 2012-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 29751
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13615204
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/615204 | Genetic Association of Polymorphisms in Perilipin (PLIN) Gene With Resistance to Weight Loss | Sep 12, 2012 | Abandoned |
Array
(
[id] => 9720229
[patent_doc_number] => 20140255930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'Materials and Methods Related to Dopamine Dysregulation Disorders'
[patent_app_type] => utility
[patent_app_number] => 14/237038
[patent_app_country] => US
[patent_app_date] => 2012-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 21633
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237038
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/237038 | Materials and Methods Related to Dopamine Dysregulation Disorders | Sep 9, 2012 | Abandoned |
Array
(
[id] => 9720235
[patent_doc_number] => 20140255936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'DETECTING FRONTOTEMPORAL DEMENTIA AND AMYOTROPHIC LATERAL SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 14/343807
[patent_app_country] => US
[patent_app_date] => 2012-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 11022
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343807
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/343807 | DETECTING FRONTOTEMPORAL DEMENTIA AND AMYOTROPHIC LATERAL SCLEROSIS | Sep 6, 2012 | Abandoned |
Array
(
[id] => 12193010
[patent_doc_number] => 09896729
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-20
[patent_title] => 'Method for diagnosing a neurodegenerative disease'
[patent_app_type] => utility
[patent_app_number] => 14/241646
[patent_app_country] => US
[patent_app_date] => 2012-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 16
[patent_no_of_words] => 19765
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14241646
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/241646 | Method for diagnosing a neurodegenerative disease | Aug 30, 2012 | Issued |
Array
(
[id] => 9917743
[patent_doc_number] => 20150072947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-12
[patent_title] => 'GENE BIOMARKERS FOR PREDICTION OF SUSCEPTIBILITY OF OVARIAN NEOPLASMS AND/OR PROGNOSIS OR MALIGNANCY OF OVARIAN CANCERS'
[patent_app_type] => utility
[patent_app_number] => 14/241803
[patent_app_country] => US
[patent_app_date] => 2012-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9290
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14241803
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/241803 | GENE BIOMARKERS FOR PREDICTION OF SUSCEPTIBILITY OF OVARIAN NEOPLASMS AND/OR PROGNOSIS OR MALIGNANCY OF OVARIAN CANCERS | Aug 29, 2012 | Abandoned |
Array
(
[id] => 9339535
[patent_doc_number] => 20140066316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'DACH1 as a Biomarker for Diabetes'
[patent_app_type] => utility
[patent_app_number] => 13/597048
[patent_app_country] => US
[patent_app_date] => 2012-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 20613
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13597048
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/597048 | DACH1 as a Biomarker for Diabetes | Aug 27, 2012 | Abandoned |
Array
(
[id] => 9330469
[patent_doc_number] => 20140057251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'Cannabis Genomes and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/588935
[patent_app_country] => US
[patent_app_date] => 2012-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 12113
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13588935
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/588935 | Cannabis Genomes and Uses Thereof | Aug 16, 2012 | Abandoned |
Array
(
[id] => 9482778
[patent_doc_number] => 08728727
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-20
[patent_title] => 'Diagnosis of hereditary spastic paraplegias (HSP) by detection of a mutation in the KIAA1840 gene or protein'
[patent_app_type] => utility
[patent_app_number] => 13/567790
[patent_app_country] => US
[patent_app_date] => 2012-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 19
[patent_no_of_words] => 17373
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13567790
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/567790 | Diagnosis of hereditary spastic paraplegias (HSP) by detection of a mutation in the KIAA1840 gene or protein | Aug 5, 2012 | Issued |
Array
(
[id] => 8767973
[patent_doc_number] => 20130096010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'HtSNPs FOR DETERMINING A GENOTYPE OF CYTOCHROME P450 1A2, 2A6 AND 2D6, PXR AND UDP-GLUCURONOSYLTRANSFERASE 1A GENE AND MULTIPLEX GENOTYPING METHODS USING THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/549873
[patent_app_country] => US
[patent_app_date] => 2012-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 29218
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13549873
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/549873 | HtSNPs FOR DETERMINING A GENOTYPE OF CYTOCHROME P450 1A2, 2A6 AND 2D6, PXR AND UDP-GLUCURONOSYLTRANSFERASE 1A GENE AND MULTIPLEX GENOTYPING METHODS USING THEREOF | Jul 15, 2012 | Abandoned |
Array
(
[id] => 8767442
[patent_doc_number] => 20130095478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'HtSNPs FOR DETERMINING A GENOTYPE OF CYTOCHROME P450 1A2, 2A6 AND 2D6, PXR AND UDP-GLUCURONOSYLTRANSFERASE 1A GENE AND MULTIPLEX GENOTYPING METHODS USING THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/549981
[patent_app_country] => US
[patent_app_date] => 2012-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 29182
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13549981
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/549981 | HtSNPs FOR DETERMINING A GENOTYPE OF CYTOCHROME P450 1A2, 2A6 AND 2D6, PXR AND UDP-GLUCURONOSYLTRANSFERASE 1A GENE AND MULTIPLEX GENOTYPING METHODS USING THEREOF | Jul 15, 2012 | Abandoned |
Array
(
[id] => 8607382
[patent_doc_number] => 20130012694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'MONUMENTAL ADORNMENT'
[patent_app_type] => utility
[patent_app_number] => 13/542289
[patent_app_country] => US
[patent_app_date] => 2012-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4224
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13542289
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/542289 | MONUMENTAL ADORNMENT | Jul 4, 2012 | Abandoned |
Array
(
[id] => 9491025
[patent_doc_number] => 20140141432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'METHOD AND KIT FOR DIAGNOSING GLAUCOMA IN DOGS'
[patent_app_type] => utility
[patent_app_number] => 14/232107
[patent_app_country] => US
[patent_app_date] => 2012-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6469
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14232107
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/232107 | METHOD AND KIT FOR DIAGNOSING GLAUCOMA IN DOGS | Jul 4, 2012 | Abandoned |
Array
(
[id] => 9517717
[patent_doc_number] => 20140154209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'POLYMORPHISMS ASSOCIATED WITH NON-RESPONSE TO A HEPATITIS C TREATMENT OR SUSCEPTIBILITY TO NON-SPONTANEOUS HEPATITIS C CLEARANCE'
[patent_app_type] => utility
[patent_app_number] => 14/125885
[patent_app_country] => US
[patent_app_date] => 2012-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16132
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125885
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/125885 | POLYMORPHISMS ASSOCIATED WITH NON-RESPONSE TO A HEPATITIS C TREATMENT OR SUSCEPTIBILITY TO NON-SPONTANEOUS HEPATITIS C CLEARANCE | Jun 28, 2012 | Abandoned |
Array
(
[id] => 8607094
[patent_doc_number] => 20130012406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'METHODS AND KITS FOR MULTIPLEX AMPLIFICATION OF SHORT TANDEM REPEAT LOCI'
[patent_app_type] => utility
[patent_app_number] => 13/530011
[patent_app_country] => US
[patent_app_date] => 2012-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9337
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13530011
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/530011 | METHODS AND KITS FOR MULTIPLEX AMPLIFICATION OF SHORT TANDEM REPEAT LOCI | Jun 20, 2012 | Abandoned |
Array
(
[id] => 8916755
[patent_doc_number] => 20130178379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-11
[patent_title] => 'Identifying Markers of Caloric Restriction and Caloric Restriction Mimetics'
[patent_app_type] => utility
[patent_app_number] => 13/525230
[patent_app_country] => US
[patent_app_date] => 2012-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13506
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13525230
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/525230 | Identifying Markers of Caloric Restriction and Caloric Restriction Mimetics | Jun 14, 2012 | Abandoned |